June 2021
Volume 62, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2021
Arginase Isoforms and Diabetic Retinopathy in the db/db Mouse
Author Affiliations & Notes
  • Katharine Leilani Bunch
    Pharmacology and Toxicology, Augusta University, Augusta, Georgia, United States
  • Ruth B Caldwell
    Vascular Biology Center, Augusta University, Augusta, Georgia, United States
    Research, Charlie Norwood VA Medical Center, Augusta, Georgia, United States
  • Robert W Caldwell
    Pharmacology and Toxicology, Augusta University, Augusta, Georgia, United States
  • Footnotes
    Commercial Relationships   Katharine Bunch, None; Ruth Caldwell, None; Robert Caldwell, None
  • Footnotes
    Support  NIH Grant 5R01EY011766-21, NIH Grant 1P30EY031631-01
Investigative Ophthalmology & Visual Science June 2021, Vol.62, 3031. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Katharine Leilani Bunch, Ruth B Caldwell, Robert W Caldwell; Arginase Isoforms and Diabetic Retinopathy in the db/db Mouse. Invest. Ophthalmol. Vis. Sci. 2021;62(8):3031.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The obese, type 2 diabetic db/db mouse has been established as suitable model for the pathogenesis of human diabetic retinopathy (DR), but the role of arginase in this model is unknown. Given the association of arginase isoforms, A1 and A2, in several models of retinopathy, we hypothesize that A1 and A2 are associated with the pathophysiology of DR in the db/db mouse. A1/A2 compete with nitric oxide synthase (NOS) for L-arginine and increased A1/A2 decreases nitric oxide (NO) levels. NO is imperative for tissue perfusion in many pathologic disease states, including stroke, DR, and cardiovascular disease (CVD). Increased NO has been shown to be protective in murine models of stroke, CVD, and DR, while A2-/- mice were protected against western diet-induced DR.

Methods : Whole eyes, retinas, and plasma were collected from 16 (n=8) and 23 week-old (n=6) female db/db mice and their DB/db (control) littermates (#000642). Globes were sectioned and immunofluorescence (IF) was performed for A1, A2, markers of inflammation, and neuroglial activation, including GFAP and IL-6. Retinas were used to western blot for proteins in the NLRP3 inflammasome cascade, products of reactive oxygen species, and hypoxia, including A1, A2, GFAP, HIF-1α, and IL-1β. Western blot signals were quantified by densitometry using ImageJ software and normalized to loading controls. Plasma was used for A1 ELISA analysis, reported in ng/mL. GraphPad Prism 9 was used to implement unpaired t-test analyses. Values of p<0.05 were considered significant.

Results : A1 levels were markedly increased in both the plasma (16 weeks p=0.011, 23 weeks p<0.0001) and retina lysates (p=0.005) of the db/db mice compared to controls. Retinal A2 was also significantly increased (p=0.0332). Markers of inflammasome activation were significantly increased in db/db retinas (Eg: IL-1β p=0.008). Hypoxia marker HIF-1α, a VEGF transcription factor, was also markedly elevated in db/db retinas (p=0.027). IF of GFAP, an indicator of neurodegeneration, showed increased expression in db/db retinas compared to controls.

Conclusions : These results are consistent with our hypothesis that A1 and A2 are linked to the pathophysiology of DR in the db/db mouse, as elevated A1 and A2 correlate with increased markers of hypoxia, inflammation, neurodegeneration in db/db mouse retina compare to controls. Further investigation is needed to elucidate the mechanistic effects of A1/A2 on the pathogenesis of db/db DR.

This is a 2021 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×